Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent. Kiran Shroff / Wednesday, January 8, 2025 / Article rating: 4.0 From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar Pharma Stock Jumps 4.5 per cent After Japan’s Nod for Injectable Biosimilar A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price. Pushkar Shinde / Tuesday, January 7, 2025 / Article rating: 5.0 A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock price.
CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why CDMO Company's Shares Surge Over 12 Per Cent in Two Trading Sessions; Here’s Why The company's shares surged 10 per cent to hit the upper circuit at Rs 668.10 on the BSE. This marked the second consecutive session of gains for the stock Manoj Reddy Sama / Friday, December 27, 2024 / Article rating: 5.0 Under the agreement, Akums will receive an upfront payment of EUR 100 million (Rs 880 crore) to fund product development and secure European regulatory approvals for its oral liquid manufacturing facility.
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share. Kiran Shroff / Thursday, December 26, 2024 / Article rating: 3.9 The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent.
Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility Multibagger Pharma Stock Rises Nearly 3 Per Cent After US FDA Observations on Telangana Facility The inspection, conducted between December 9 and December 17, 2024, resulted in two procedural observations from the US FDA. Manoj Reddy Sama / Wednesday, December 18, 2024 / Article rating: 4.3 The facility in question, Unit-V, is an active pharmaceutical ingredient (API) manufacturing site operated by Apitoria Pharma Private Ltd, a wholly owned subsidiary of Aurobindo Pharma, located in Pashamylaram Village, Telangana.
Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl Pharma penny stock under Rs 60 jumps after company received communication from EDQM on CEP filing of Propafenone HCl From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent. Kiran Shroff / Friday, November 29, 2024 / Article rating: 4.0 From Rs 43.42 per share (52-week low) to Rs 54.90 per share, the stock is up by 26.40 per cent.
FIIs and DIIs Increase Stake: Small-cap Pharma Company Reports Over 11 Times Jump in Net Profit FIIs and DIIs Increase Stake: Small-cap Pharma Company Reports Over 11 Times Jump in Net Profit The company reported an impressive over 11 times growth in net profit for the second quarter of FY25, with Profit After Tax (PAT) reaching Rs 17.94 crore compared to Rs 1.61 crore in the same period last year. Manoj Reddy Sama / Thursday, November 14, 2024 / Article rating: 4.0 Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) significantly increased their holdings in Shilpa Medicare during Q2 of FY25.
Mukul Agrawal gains Rs 1,10,29,80,000 & Vijay Kedia gains 35,84,68,500 from this multibagger pharma stock; Scrip hit 20 per cent upper circuit & 52-week high Mukul Agrawal gains Rs 1,10,29,80,000 & Vijay Kedia gains 35,84,68,500 from this multibagger pharma stock; Scrip hit 20 per cent upper circuit & 52-week high The shares of the company saw a spurt in volume by more than 2 times. Kiran Shroff / Tuesday, November 12, 2024 / Article rating: 5.0 The stock gave multibagger returns of 200 per cent in 1 year, 850 per cent in 3 years and a whopping 3,000 per cent in 5 years.
Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! Indian Pharma Company Scores Major USFDA Approval for Game-Changing Capsule, Plans 5+ New Product Launches! With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence Pushkar Shinde / Monday, November 11, 2024 / Article rating: 5.0 With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product portfolio and strengthen its global presence